Clinical Complete Response After Conversion Therapy for Unresectable Hepatocellular Carcinoma: Is Salvage Hepatectomy Necessary?
Jiayi Wu(Sun Yat-sen University), Yaodong Wang(Fujian Medical University), Shao-Wu Zhuang(Fujian Medical University), Jianyin Zhou(Zhongshan Hospital of Xiamen University), Bin Li(Sun Yat-sen University), Zhi‐Bo Zhang(Fujian Medical University), Han Li(Liuzhou General Hospital), De-Yi Liu(Fujian Medical University), Shu-Qun Li(Guilin Medical University), Jingyao Huang(Fujian Medical University), Mao-Lin Yan(Fujian Medical University)
Cited by 12
Related Papers
Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment
|Nature Communications|2020|478
MicroRNA-377 suppresses initiation and progression of esophageal cancer by inhibiting CD133 and VEGF
|Oncogene|2017|141
Co-delivery of paclitaxel and TOS-cisplatin via TAT-targeted solid lipid nanoparticles with synergistic antitumor activity against cervical cancer
|International Journal of Nanomedicine|2017|128